
News|Articles|July 1, 2006
Antihypertensives demonstrate benefit in reducing Alzheimer's disease risk
Potassium-sparing diuretics reduced the risk of Alzheimer's disease (AD) by >70% in patients aged >64 years while other antihypertensive (AH) medications, including all diuretics, beta blockers, and dihydropyridine calcium channel blockers, were linked with somewhat smaller decreases in Alzheimer's risk.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Patient-facing EHR tool improves lung cancer screening identification
2
New therapies on the way to lower Lp(a), a cardiovascular risk factor
3
Newer biologics show strong drug survival for psoriasis patients
4
Children’s Hospital of Philadelphia and Soar Autism Center launch early autism care network
5






















































